Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar

Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

Celltrion Healthcare's Herzuma selected as funded brand in NZ

Celltrion Healthcare's Herzuma selected as funded brand in NZ

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials

Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials

Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...

President Lee meets Hyundai, LG chiefs, promotes ‘one team’ approach Hanwan Ocean wins $1.4 bn order to build 7 LNG dual-fuel ships K-content reign continues as Squid Game returns in force South Korea’s EV exports rebound in June after 16-month decline Yes, it’s K-beauty: Strong buying appetite for makeup brands even before they're up for sale
banner